166 related articles for article (PubMed ID: 32492993)
1. Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
Sharma A; Surve R; Dhurat R; Sinclair R; Tan T; Zou Y; Müller Ramos P; Wambier C; Verner I; Kovacevic M; Goren A
J Biol Regul Homeost Agents; 2020; 34(2):659-661. PubMed ID: 32492993
[No Abstract] [Full Text] [Related]
2. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
Sharma A; Goren A; Dhurat R; Agrawal S; Sinclair R; Trüeb RM; Vañó-Galván S; Chen G; Tan Y; Kovacevic M; Situm M; McCoy J
Dermatol Ther; 2019 May; 32(3):e12915. PubMed ID: 30974011
[TBL] [Abstract][Full Text] [Related]
3. Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.
Mehta N; Huang S; Dhura R; Wambier C; do Nascimento Fonesca D; Little S; Goren A
J Cosmet Dermatol; 2024 Jan; 23(1):339-343. PubMed ID: 37638619
[TBL] [Abstract][Full Text] [Related]
4. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
5. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.
Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J
Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287
[TBL] [Abstract][Full Text] [Related]
6. Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response.
Ramos PM; McCoy J; Wambier C; Shapiro J; Vañó-Galvan S; Sinclair R; Goren A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e799-e800. PubMed ID: 32432358
[No Abstract] [Full Text] [Related]
7. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth.
Dhurat R; Daruwalla S; Pai S; Kovacevic M; McCoy J; Shapiro J; Sinclair R; Vano-Galvan S; Goren A
J Cosmet Dermatol; 2022 Jan; 21(1):343-346. PubMed ID: 34133836
[TBL] [Abstract][Full Text] [Related]
8. The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
Goren A; Mccoy J; Kovacevic M; Situm M; Chitalia J; Dhurat R; Naccarato T; Lotti T
J Biol Regul Homeost Agents; 2018; 32(4):937-940. PubMed ID: 30043580
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia.
Shah KB; Shah AN; Solanki RB; Raval RC
Int J Trichology; 2017; 9(1):14-18. PubMed ID: 28761259
[TBL] [Abstract][Full Text] [Related]
10. Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil.
McCoy J; Goren A; Naccarato T; Kovacevic M; Situm M; Skudar VL; Lotti T
J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):817-819. PubMed ID: 31184104
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
12. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
[TBL] [Abstract][Full Text] [Related]
13. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
15. Microneedling and Platelet-Rich Plasma versus Microneedling and 5% Topical Minoxidil Therapy in Male Pattern Hair Loss.
Gozali MM; Kurniawati Y; Zulkarnain SD
Skinmed; 2020; 18(3):176-178. PubMed ID: 32790616
[TBL] [Abstract][Full Text] [Related]
16. Topical minoxidil: review of efficacy and safety.
Katz HI
Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
[TBL] [Abstract][Full Text] [Related]
17. Topical minoxidil in the treatment of androgenetic alopecia in women.
Olsen EA
Cutis; 1991 Sep; 48(3):243-8. PubMed ID: 1935254
[TBL] [Abstract][Full Text] [Related]
18. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia.
Goren A; Castano JA; McCoy J; Bermudez F; Lotti T
Dermatol Ther; 2014; 27(3):171-3. PubMed ID: 24283387
[TBL] [Abstract][Full Text] [Related]
19. Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent.
Chitalia J; Dhurat R; Goren A; McCoy J; Kovacevic M; Situm M; Naccarato T; Lotti T
Dermatol Ther; 2018 Nov; 31(6):e12688. PubMed ID: 30295395
[TBL] [Abstract][Full Text] [Related]
20. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
